Sunday, June 26th, 2022

Global Molluscum Contagiosum Market Industry Overview 2022

Molluscum Contagiosum Market Industry Overview:

The Molluscum Contagiosum Market study contains data on the global business, as well as useful facts and figures. The Global Market is examined in depth in this research report, including industry chain structures, raw material suppliers, and manufacturing. The Molluscum Contagiosum market investigates the market’s most important segments. This insightful study combines historical data with projections for the years 2022 to 2026.

This report investigates the entire value chain, as well as downstream and upstream essentials. Globalization and economic growth are driving fragmentation regulatory and environmental concerns. This Market research describes which product has the largest penetration, profit margins, and R & D status, as well as technical data, manufacturing plant analysis, and raw material sources analysis of Molluscum Contagiosum Industry. The study makes forecasts for the future based on an examination of the market’s subdivisions, which include the global market size by product category, end-user application, and several regions.

The global Molluscum Contagiosum Market is projected to grow from 49.9 billion in 2021 to 89.58 billion in 2026 at a CAGR of 10.3% during forecast period.

FREE | Request Sample is Available @


A poxvirus causes the infection Molluscum contagiosum (MC) (Molluscum contagiosum virus). The infection causes benign lesions on the upper layer of the skin and can be spread through direct skin contact. Children aged 1–14 years are more likely to be infected by the virus, according to data published by the National Centre for Biotechnology Information, with an incidence rate ranging from 12 to 14 cases per 1000 children each year. According to the National Disease and Therapeutic Index Survey, Molluscum contagiosum is the most frequent skin ailment in the United States, accounting for around 1% of all skin illnesses.

Some of the Top companies Influencing in this Molluscum Contagiosum Market Overview include:
On 27th November 2019: Verrica Pharmaceuticals announced the approval of new drug application   By FDA for VP-102 (cantharidin 0.7% Topical Solution) for the treatment of MC
On 2nd January 2020: Novan,Inc. reported results for pipeline drug SB206, which is being evaluated for the treatment of MC in Phase 3 of the clinical trials
On 5th October 2018: Novan,Inc signed an out-licensing agreement with Sato Pharmaceutical Co., Ltd to develop and sell SB206 product in Japan
On October 2018: Veloce BioPharma LLC reported completion of Phase 2 clinical trial for Topical Gel VBP-245 in Pediatric Patients with MC
On 1st October 2015: Gurina Foundation reported Phase 3 trial results, i.e., efficacy and tolerance of Potassium Hydroxide (10% and 15%) in children suffering from MC.

About Us: is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Contact Us:

Email: [email protected]
825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846

Leave a Reply

Your email address will not be published.